Observational studyClinical cardiology2019

Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study.

Sailaja Kamaraju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.